RxDoctor Payments Data
★ My doctorsLook up a doctor →

Anwar Tandar, MD

Interventional Cardiology · Salt Lake City, UTNPI 1154538148

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $81,915 of the $131,477 with a category attached, or 62.3%. 12 manufacturers reported payments, led by Edwards Lifesciences at 37.9% of the total. 2025 is the largest year on record at $51,151, 2.2 times the $22,910 reported in 2019. Among interventional cardiology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$131,477in general payments, 2019–2025

Across 259 payments — averaging $507.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$50K
  • W. L. Gore & Associates, Inc.$44K
  • Boston Scientific$28K
  • Merit Medical Systems Inc$4K
  • Medtronic$2K
  • Abbott$1K
  • plus $3K from 6 others
$356,448in research payments, 2019–2025

Across 83 payments — averaging $4294.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • W. L. Gore & Associates, Inc.$202K
  • Abbott$73K
  • Medical Device Business Services, Inc.$37K
  • Boston Scientific$25K
  • Edwards Lifesciences$20K

What the payments were for

  • Consulting fees$81,91562%
  • Speaking & faculty fees$11,6009%
  • Travel & lodging$27,05921%
  • Food & beverage$10,8098%
  • Education$940%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences123$49,852
W. L. Gore & Associates, Inc.43$43,885
Boston Scientific41$27,833
Merit Medical Systems Inc3$3,900
Medtronic(2 entities)16$2,184
Abbott12$1,128
Shockwave Medical, Inc5$909
Philips North America LLC6$787
Artivion, Inc.2$719
Abiomed3$148
Biotronik Inc.4$94
Recor Medical Inc1$38

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$131,477 in reported general payments places this provider in the 95th percentile of 45 interventional cardiology providers in Utah.

See all interventional cardiology providers in Utah →

Medicare billing

Part B allowed, 2024
$173,552
Medicare patients
374
Services billed
930

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin33$25,671
EliquisApixaban11$13,471
Ezetimibe14$458
Metoprolol Succinate35$419
Rosuvastatin Calcium20$375
ClopidogrelClopidogrel Bisulfate14$147
Atorvastatin Calcium24$128
Lisinopril14$97
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide14$88
Carvedilol18$65
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid12$64
Metoprolol Tartrate18$59
Cephalexin13$40

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Salt Lake City

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →